Successful Treatment of Post COVID-19 Neurogenic Dysphagia with Botulinum Toxin.

European journal of case reports in internal medicine 2023 Vol.10(12) p. 004105

Canta R, Vestito L, Castellini P, Trompetto C, Mori L, De Giovanni A, Puce L, Marinelli L

관련 도메인

Abstract

[INTRODUCTION] Dysphagia in post COVID-19 patients could be caused by several factors, including reduced pharyngolaryngeal coordination due to SARS-CoV-2 tropism to the central and/or peripheral nervous system. To our knowledge, this is the first reported case of COVID-19-related dysphagia successfully treated with botulinum toxin type A injection.

[CASE DESCRIPTION] We report the case of a patient with severe oropharyngeal dysphagia due to COVID-19 confirmed by fibre endoscopy. As a result, the patient required an enteral feeding tube. After two months of traditional swallowing therapies, there was only limited improvement. An electrophysiologic evaluation of the cricopharyngeal muscle was performed and showed a normal inhibition of the cricopharyngeal muscle, followed by a hypertonic rebound. Based on this result, we decided to perform a unilateral laryngeal injection of botulinum toxin type A. After the injection, the patient's swallowing function improved significantly, allowing him to return to oral feeding.

[DISCUSSION] Newly diagnosed oropharyngeal dysphagia was found in 35.3% of hospitalised patients with COVID-19. There are several possible causes of COVID-19-associated dysphagia, including stroke, encephalitis, critical illness neuropathy, Guillain-Barré syndrome and skeletal muscle injury. In our case, since stroke was excluded by brain MRI, cranial nerve injury was a possible explanation for the difficult recovery of swallowing despite daily swallowing therapy.

[CONCLUSION] We suggest that electrophysiology is a valid tool for the diagnosis and follow-up of patients with oropharyngeal dysphagia.

[LEARNING POINTS] SARS-CoV-2 tropism to the central and/or peripheral nervous system can cause dysphagia in post COVID-19 patients.An electrophysiologic approach is useful for the diagnosis and follow-up of patients with oropharyngeal dysphagia.A single botulinum toxin type A injection is a valid treatment option to improve the swallowing function in patients with post COVID-19 dysphagia.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 4
해부 enteral feeding scispacy 1
해부 muscle scispacy 1
해부 laryngeal scispacy 1
해부 oral scispacy 1
해부 skeletal muscle scispacy 1
해부 brain scispacy 1
합병증 pharyngolaryngeal scispacy 1
합병증 peripheral nervous scispacy 1
합병증 oropharyngeal dysphagia scispacy 1
약물 [INTRODUCTION] Dysphagia scispacy 1
약물 COVID-19 scispacy 1
약물 [LEARNING POINTS] SARS-CoV-2 scispacy 1
기법 endoscopy 내시경 dict 1
질환 Neurogenic Dysphagia C1955520
Neurogenic dysphagia
scispacy 1
질환 Dysphagia C0011168
Deglutition Disorders
scispacy 1
질환 including reduced pharyngolaryngeal coordination scispacy 1
질환 COVID-19-related dysphagia scispacy 1
질환 oropharyngeal dysphagia C0267071
Oropharyngeal Dysphagia
scispacy 1
질환 COVID-19-associated dysphagia scispacy 1
질환 stroke C0038454
Cerebrovascular accident
scispacy 1
질환 encephalitis C0014038
Encephalitis
scispacy 1
질환 illness neuropathy scispacy 1
질환 Guillain-Barré syndrome C0018378
Guillain-Barre Syndrome
scispacy 1
질환 skeletal muscle injury scispacy 1
질환 cranial nerve injury C0273483
Cranial Nerve Injuries
scispacy 1
질환 COVID-19 dysphagia scispacy 1
기타 COVID-19 scispacy 1
기타 patients scispacy 1
기타 patient scispacy 1
기타 Guillain-Barré scispacy 1
기타 cranial nerve scispacy 1

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문